Cancer immunotherapy hit the headlines again yesterday - this time off the back of the award of the 2018 Nobel Prize in Physiology or Medicine to two of its scientific pioneers.
James Allison at the University of Texas MD Anderson Cancer Center in Houston and Tasuku Honjo at Kyoto University in Japan will share the 9 million Swedish kronor (US$1 million) prize.
Their groundbreaking work on how proteins on immune cells can be use to manipulate the body's own immune system so that it attacks cancer cell has led to the development of some exciting new cancer therapies - some of which are having extraordinary results for some patients. And, as I'm sure you will be all too aware, immunotherapy is now one of the hottest topics in cancer research!
You can read more about their story on the Nature website.
Keeping the cancer-immune setpoint up-to-date
But we still don't understand why immunotherapies work better in some patients than others.
We're building a community of cancer immunologists who share their knowledge to collate all the factors involved in how a tumour responds to treatment. This invaluable resource could help advance immunotherapy research, and ultimately, help more patients to reap the rewards from these pioneering new treatments.
But we need your help to keep it updated. Please
To help get you started, please follow our a simple step-by-step guide in our.